Cargando…
Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities
Tumefactive multiple sclerosis comprises a rare subset of multiple sclerosis that often poses a diagnostic challenge to physicians. It is unique in its presentation as a solitary lesion, usually larger than 2 cm, with surrounding vasogenic edema, commonly mimicking a primary intracranial malignancy....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423083/ https://www.ncbi.nlm.nih.gov/pubmed/37575699 http://dx.doi.org/10.7759/cureus.41845 |
_version_ | 1785089367813914624 |
---|---|
author | ElSaygh, Jude Kandinova, Nicole Zaher, Anas Sunner, Gurinder K Kostanyan, Sofya |
author_facet | ElSaygh, Jude Kandinova, Nicole Zaher, Anas Sunner, Gurinder K Kostanyan, Sofya |
author_sort | ElSaygh, Jude |
collection | PubMed |
description | Tumefactive multiple sclerosis comprises a rare subset of multiple sclerosis that often poses a diagnostic challenge to physicians. It is unique in its presentation as a solitary lesion, usually larger than 2 cm, with surrounding vasogenic edema, commonly mimicking a primary intracranial malignancy. We present a case of a 25-year-old female with no significant past medical history who presented to our institution with homonymous superior quadrantanopia. During her admission, she underwent a magnetic resonance imaging (MRI) of the brain, which revealed a large lesion in the left temporal area surrounded by marked edema. A thorough workup revealed a diagnosis of tumefactive multiple sclerosis. Subsequently, she was initiated on intravenous immunoglobulin rather than stress dose steroids, given the concern for a superimposed infection. Interestingly, the patient had a paradoxical progression of her symptoms as well as expansion of the vasogenic edema on a repeat MRI. In our case, we highlight the key differences in tumefactive multiple sclerosis diagnosis and management. |
format | Online Article Text |
id | pubmed-10423083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-104230832023-08-13 Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities ElSaygh, Jude Kandinova, Nicole Zaher, Anas Sunner, Gurinder K Kostanyan, Sofya Cureus Internal Medicine Tumefactive multiple sclerosis comprises a rare subset of multiple sclerosis that often poses a diagnostic challenge to physicians. It is unique in its presentation as a solitary lesion, usually larger than 2 cm, with surrounding vasogenic edema, commonly mimicking a primary intracranial malignancy. We present a case of a 25-year-old female with no significant past medical history who presented to our institution with homonymous superior quadrantanopia. During her admission, she underwent a magnetic resonance imaging (MRI) of the brain, which revealed a large lesion in the left temporal area surrounded by marked edema. A thorough workup revealed a diagnosis of tumefactive multiple sclerosis. Subsequently, she was initiated on intravenous immunoglobulin rather than stress dose steroids, given the concern for a superimposed infection. Interestingly, the patient had a paradoxical progression of her symptoms as well as expansion of the vasogenic edema on a repeat MRI. In our case, we highlight the key differences in tumefactive multiple sclerosis diagnosis and management. Cureus 2023-07-13 /pmc/articles/PMC10423083/ /pubmed/37575699 http://dx.doi.org/10.7759/cureus.41845 Text en Copyright © 2023, ElSaygh et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine ElSaygh, Jude Kandinova, Nicole Zaher, Anas Sunner, Gurinder K Kostanyan, Sofya Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities |
title | Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities |
title_full | Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities |
title_fullStr | Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities |
title_full_unstemmed | Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities |
title_short | Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities |
title_sort | tumefactive multiple sclerosis: challenges with treatment modalities |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423083/ https://www.ncbi.nlm.nih.gov/pubmed/37575699 http://dx.doi.org/10.7759/cureus.41845 |
work_keys_str_mv | AT elsayghjude tumefactivemultiplesclerosischallengeswithtreatmentmodalities AT kandinovanicole tumefactivemultiplesclerosischallengeswithtreatmentmodalities AT zaheranas tumefactivemultiplesclerosischallengeswithtreatmentmodalities AT sunnergurinderk tumefactivemultiplesclerosischallengeswithtreatmentmodalities AT kostanyansofya tumefactivemultiplesclerosischallengeswithtreatmentmodalities |